vs
Amphastar Pharmaceuticals, Inc.（AMPH）とConcrete Pumping Holdings, Inc.（BBCP）の財務データ比較。上の社名をクリックして会社を切り替えられます
Amphastar Pharmaceuticals, Inc.の直近四半期売上が大きい（$183.1M vs $98.9M、Concrete Pumping Holdings, Inc.の約1.9倍）。Amphastar Pharmaceuticals, Inc.の純利益率が高く（13.3% vs 5.4%、差は8.0%）。Amphastar Pharmaceuticals, Inc.の前年同期比売上増加率が高い（-1.8% vs -3.2%）。Amphastar Pharmaceuticals, Inc.の直近四半期フリーキャッシュフローが多い（$24.6M vs $1.9M）。過去8四半期でConcrete Pumping Holdings, Inc.の売上複合成長率が高い（4.8% vs 3.2%）
Amphastar Pharmaceuticalsは上場されている米国の特殊製薬企業です。2004年5月に設立され、主に吸入剤および鼻腔内投与製品の開発、生産、販売を行っており、特色ある医薬品分野で事業を展開しています。
コンクリートポンピングホールディングス社は、米国と英国を中心にコンクリートポンプサービスおよび関連機器のレンタルを提供する大手企業です。インフラ工事、商業不動産開発、住宅建設などの分野で、効率的かつ安全なコンクリート打設を支援しています。
AMPH vs BBCP — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $183.1M | $98.9M |
| 純利益 | $24.4M | $5.3M |
| 粗利率 | 46.8% | 43.8% |
| 営業利益率 | 19.4% | 17.0% |
| 純利益率 | 13.3% | 5.4% |
| 売上前年比 | -1.8% | -3.2% |
| 純利益前年比 | -35.7% | -43.6% |
| EPS（希薄化後） | $0.51 | $0.09 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $183.1M | $98.9M | ||
| Q3 25 | $191.8M | $94.2M | ||
| Q2 25 | $174.4M | $85.2M | ||
| Q1 25 | $170.5M | $78.0M | ||
| Q4 24 | $186.5M | $102.1M | ||
| Q3 24 | $191.2M | $100.6M | ||
| Q2 24 | $182.4M | $98.7M | ||
| Q1 24 | $171.8M | $90.0M |
| Q4 25 | $24.4M | $5.3M | ||
| Q3 25 | $17.4M | $3.7M | ||
| Q2 25 | $31.0M | $-4.0K | ||
| Q1 25 | $25.3M | $-2.6M | ||
| Q4 24 | $38.0M | $9.4M | ||
| Q3 24 | $40.4M | $7.6M | ||
| Q2 24 | $37.9M | $3.0M | ||
| Q1 24 | $43.2M | $-3.8M |
| Q4 25 | 46.8% | 43.8% | ||
| Q3 25 | 51.4% | 42.9% | ||
| Q2 25 | 49.6% | 42.5% | ||
| Q1 25 | 50.0% | 40.0% | ||
| Q4 24 | 46.5% | 45.3% | ||
| Q3 24 | 53.3% | 44.3% | ||
| Q2 24 | 52.2% | 42.3% | ||
| Q1 24 | 52.4% | 37.0% |
| Q4 25 | 19.4% | 17.0% | ||
| Q3 25 | 13.2% | 13.7% | ||
| Q2 25 | 24.2% | 9.7% | ||
| Q1 25 | 21.9% | 4.5% | ||
| Q4 24 | 24.2% | 18.8% | ||
| Q3 24 | 29.8% | 16.5% | ||
| Q2 24 | 30.3% | 12.2% | ||
| Q1 24 | 27.9% | 1.6% |
| Q4 25 | 13.3% | 5.4% | ||
| Q3 25 | 9.0% | 3.9% | ||
| Q2 25 | 17.8% | -0.0% | ||
| Q1 25 | 14.8% | -3.4% | ||
| Q4 24 | 20.4% | 9.2% | ||
| Q3 24 | 21.1% | 7.5% | ||
| Q2 24 | 20.8% | 3.1% | ||
| Q1 24 | 25.1% | -4.3% |
| Q4 25 | $0.51 | $0.09 | ||
| Q3 25 | $0.37 | $0.07 | ||
| Q2 25 | $0.64 | $-0.01 | ||
| Q1 25 | $0.51 | $-0.06 | ||
| Q4 24 | $0.74 | $0.16 | ||
| Q3 24 | $0.78 | $0.13 | ||
| Q2 24 | $0.73 | $0.05 | ||
| Q1 24 | $0.81 | $-0.08 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $282.8M | $44.4M |
| 総負債低いほど良い | $608.7M | $417.9M |
| 株主資本純資産 | $788.8M | $264.8M |
| 総資産 | $1.6B | $879.5M |
| 負債/資本比率低いほどレバレッジが低い | 0.77× | 1.58× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $282.8M | $44.4M | ||
| Q3 25 | $276.2M | $41.0M | ||
| Q2 25 | $231.8M | $37.8M | ||
| Q1 25 | $236.9M | $85.1M | ||
| Q4 24 | $221.6M | $43.0M | ||
| Q3 24 | $250.5M | $26.3M | ||
| Q2 24 | $217.8M | $18.0M | ||
| Q1 24 | $289.6M | $14.7M |
| Q4 25 | $608.7M | $417.9M | ||
| Q3 25 | $608.6M | $417.6M | ||
| Q2 25 | $607.7M | $417.3M | ||
| Q1 25 | $603.9M | $417.1M | ||
| Q4 24 | $601.6M | $373.3M | ||
| Q3 24 | $596.4M | $372.9M | ||
| Q2 24 | $586.9M | $372.6M | ||
| Q1 24 | $594.0M | $372.2M |
| Q4 25 | $788.8M | $264.8M | ||
| Q3 25 | $776.7M | $261.3M | ||
| Q2 25 | $757.5M | $261.8M | ||
| Q1 25 | $751.3M | $260.7M | ||
| Q4 24 | $732.3M | $321.7M | ||
| Q3 24 | $727.7M | $314.7M | ||
| Q2 24 | $713.3M | $308.3M | ||
| Q1 24 | $672.4M | $307.9M |
| Q4 25 | $1.6B | $879.5M | ||
| Q3 25 | $1.7B | $886.0M | ||
| Q2 25 | $1.6B | $878.8M | ||
| Q1 25 | $1.6B | $912.9M | ||
| Q4 24 | $1.6B | $898.0M | ||
| Q3 24 | $1.5B | $890.8M | ||
| Q2 24 | $1.5B | $894.7M | ||
| Q1 24 | $1.6B | $894.8M |
| Q4 25 | 0.77× | 1.58× | ||
| Q3 25 | 0.78× | 1.60× | ||
| Q2 25 | 0.80× | 1.59× | ||
| Q1 25 | 0.80× | 1.60× | ||
| Q4 24 | 0.82× | 1.16× | ||
| Q3 24 | 0.82× | 1.19× | ||
| Q2 24 | 0.82× | 1.21× | ||
| Q1 24 | 0.88× | 1.21× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $32.9M | $14.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $24.6M | $1.9M |
| FCFマージンFCF / 売上 | 13.4% | 1.9% |
| 設備投資強度設備投資 / 売上 | 4.5% | 12.7% |
| キャッシュ転換率営業CF / 純利益 | 1.35× | 2.72× |
| 直近12ヶ月FCF直近4四半期 | $121.2M | $17.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $32.9M | $14.5M | ||
| Q3 25 | $52.6M | $19.1M | ||
| Q2 25 | $35.6M | $24.7M | ||
| Q1 25 | $35.1M | $6.0M | ||
| Q4 24 | $29.0M | $22.4M | ||
| Q3 24 | $60.0M | $35.0M | ||
| Q2 24 | $69.1M | $9.1M | ||
| Q1 24 | $55.3M | $20.3M |
| Q4 25 | $24.6M | $1.9M | ||
| Q3 25 | $47.2M | $4.3M | ||
| Q2 25 | $25.0M | $11.1M | ||
| Q1 25 | $24.4M | $191.0K | ||
| Q4 24 | $16.6M | $16.1M | ||
| Q3 24 | $46.2M | $26.4M | ||
| Q2 24 | $63.1M | $-1.9M | ||
| Q1 24 | $46.5M | $2.5M |
| Q4 25 | 13.4% | 1.9% | ||
| Q3 25 | 24.6% | 4.6% | ||
| Q2 25 | 14.3% | 13.0% | ||
| Q1 25 | 14.3% | 0.2% | ||
| Q4 24 | 8.9% | 15.8% | ||
| Q3 24 | 24.1% | 26.2% | ||
| Q2 24 | 34.6% | -1.9% | ||
| Q1 24 | 27.1% | 2.8% |
| Q4 25 | 4.5% | 12.7% | ||
| Q3 25 | 2.8% | 15.7% | ||
| Q2 25 | 6.1% | 16.0% | ||
| Q1 25 | 6.3% | 7.5% | ||
| Q4 24 | 6.7% | 6.2% | ||
| Q3 24 | 7.2% | 8.6% | ||
| Q2 24 | 3.3% | 11.2% | ||
| Q1 24 | 5.1% | 19.7% |
| Q4 25 | 1.35× | 2.72× | ||
| Q3 25 | 3.03× | 5.16× | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.76× | 2.38× | ||
| Q3 24 | 1.48× | 4.63× | ||
| Q2 24 | 1.82× | 3.00× | ||
| Q1 24 | 1.28× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
BBCP
| US Concrete Pumping | $72.2M | 73% |
| US Concrete Waste Management Services | $21.3M | 22% |
| Other | $5.4M | 5% |
